NDC 54738-953

ribavirin

Ribavirin

ribavirin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Richmond Pharmaceuticals, Inc.. The primary component is Ribavirin.

Product ID54738-953_40db910b-e769-4a1a-ac96-e14720af471b
NDC54738-953
Product TypeHuman Prescription Drug
Proprietary Nameribavirin
Generic NameRibavirin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2007-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA076203
Labeler NameRichmond Pharmaceuticals, Inc.
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 54738-953-18

180 CAPSULE in 1 BOTTLE, PLASTIC (54738-953-18)
Marketing Start Date2007-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 54738-953-56 [54738095356]

ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2017-09-25

NDC 54738-953-84 [54738095384]

ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2017-09-25

NDC 54738-953-18 [54738095318]

ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2017-09-25

NDC 54738-953-42 [54738095342]

ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2017-09-25

NDC 54738-953-70 [54738095370]

ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2017-09-25

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:b1397a52-d99f-44f0-8649-8ceb8e7b9b85
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312817

    • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    NDC Crossover Matching brand name "ribavirin" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    68084-179RibavirinRibavirin
    68382-046RibavirinRibavirin
    68382-260RibavirinRibavirin
    68382-129RibavirinRibavirin
    68382-128RibavirinRibavirin
    68382-395RIBAVIRINRIBAVIRIN
    68382-127RibavirinRibavirin
    68682-019RibavirinRibavirin
    65862-290RibavirinRibavirin
    68475-003RIBAVIRINRIBAVIRIN
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0187-0007VirazoleRibavirin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.